Long‑term response to sequential treatment with tyrosine kinase inhibitors in a patient with EGFR+ adenocarcinoma – case report
MUDr. Bc. Petr Zůna
Klinika pneumologie 3. LF UK a Nemocnice Na Bulovce, Praha
Lung cancer is one of the tumours with very bad prognosis. Patients with epidermal growth factor receptor (EGFR) positive lung cancer are treated with tyrosine kinase inhibitors with good treatment tolerance and statistically significant improved survival outcome. Case report presents long survival of the 78 years old patient with EGFR positive non-small cell lung cancer on targeted therapy.
non-small cell lung cancer, EGFR
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...